1887

Abstract

Summary

Antimicrobial resistance among 1991 isolates collected at 24 UK hospitals during late 1993 was surveyed. Three-hundred and seventy-two of the isolates were resistant, or had reduced susceptibility, to some or all of azlocillin, carbenicillin, ceftazidime, imipenem and meropenem, and the mechanisms underlying their behaviour were examined. Only 13 isolates produced secondary β-lactamases: Six possessed PSE-1 or PSE-4 enzymes and seven had novel OXA enzyme types. Those with PSE types were highly resistant to azlocillin and carbenicillin whereas those with OXA enzymes were less resistant to these penicillins. Chromosomal -lactamase derepression was demonstrated in 54 isolates, most of which were resistant to ceftazidime and azlocillin although susceptible to carbenicillin and carbapenems. -Lactamase-independent “intrinsic” resistance occurred in 277 isolates and is believed to reflect some combination of impermeability and efflux. Two forms were seen: The classical type, present in 195 isolates, gave carbenicillin resistance (MIC > 128 mg/L) and reduced susceptibility to ciprofloxacin and to all -lactam agents except imipenem; a novel variant, seen in 82 isolates, affected only azlocillin, ceftazidime and, to a small extent, meropenem. Resistance to imipenem was largely dissociated from that to other -lactam agents, and probably reflected loss of D2 porin, whereas resistance to meropenem was mostly associated with intrinsic resistance to penicillins and cephalosporins. Comparison of the present results with those of a similar study in 1982 revealed significant increases in the proportions of isolates with intrinsic resistance or stable derepression (p ≪0.01, test). Isolates with secondary -lactamases appeared significantly rarer than in 1982 (p ≪ 0.01, test), but this comparison was distorted by outbreak strains.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-43-4-300
1995-10-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/43/4/medmicro-43-4-300.html?itemId=/content/journal/jmm/10.1099/00222615-43-4-300&mimeType=html&fmt=ahah

References

  1. Livermore D. M., Yang Y.-J. β-Lactamase lability and inducer power of newer β-lactam antibiotics in relation to their activity against β-lactamase-inducibility mutants of Pseudomonas aeruginosa. J Infect Dis 1987; 155:775–782
    [Google Scholar]
  2. Livermore D. M., Yang Y. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms. J Antimicrob Chemother 1989; 24: Suppl A 149–159
    [Google Scholar]
  3. Livermore D. M. β-Lactamases of Pseudomonas aeruginosa. In Schönfeld H. (series ed) Antibiotics and chemotherapy vol 44 Homma J. Y., Tanimoto H., Older I. A., Horby N., Döring G. (vol. eds) Pseudomonas aeruginosa in human diseases Basel: Karger; 1991215–220
    [Google Scholar]
  4. Jacoby G. A., Sutton L. Activity of β-lactam antibiotics against Pseudomonas aeruginosa carrying R-plasmids determining different β-lactamases. Antimicrob Agents Chemother 1979; 16:243–245
    [Google Scholar]
  5. Livermore D. M. Penicillin-binding proteins, porins and outer-membrane permeability of carbenicillin-resistant and -susceptible strains of Pseudomonas aeruginosa. J Med Microbiol 1984; 18:261–270
    [Google Scholar]
  6. Masuda N., Ohya S. Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1992; 36:1847–1851
    [Google Scholar]
  7. Li X.-Z., Livermore D. M., Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother 1994; 38:1732–1741
    [Google Scholar]
  8. Li X.-Z., Ma D., Livermore D. M., Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother 1994; 38:1732–1741
    [Google Scholar]
  9. Buscher K. H., Cullmann W., Dick W., Opferkuch W. Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein. Antimicrob Agents Chemother 1986; 31:703–708
    [Google Scholar]
  10. Trias J., Nikaido H. Outer membrane protein D2 catalyzes the facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1990; 34:52–57
    [Google Scholar]
  11. Chen H. Y., Yuan M., Ibrahim-Elmagboul I. B., Livermore D. M. Susceptibility and resistance to antimicrobials amongst Pseudomonas aeruginosa isolates collected in the UK in 1993. J Antimicrob Chemother 1995; 35:521–534
    [Google Scholar]
  12. Williams R. J., Lindridge M. A., Said A. A., Livermore D. M., Williams J. D. National survey of antibiotic resistance in Pseudomonas aeruginosa. J Antimicrob Chemother 1984; 14:9–16
    [Google Scholar]
  13. Williams R. J., Livermore D. M., Lindridge M. A., Said A. A., Williams J. D. Mechanisms of β-lactam resistance in British isolates of Pseudomonas aeruginosa. J Med Microbiol 1984; 17:283–293
    [Google Scholar]
  14. Livermore D. M., Corkill J. E. Effects of CO2 and pH on inhibition of TEM-1 and other β-lactamases by penicillanic acid sulfones. Antimicrob Agents Chemother 1992; 36:1870–1876
    [Google Scholar]
  15. Matthew M., Harris A. M., Marshall M. J., Ross G. W. The use of analytical isoelectric focusing for detection and identification of beta-lactamases. J Gen Microbiol 1975; 88:169–178
    [Google Scholar]
  16. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265–275
    [Google Scholar]
  17. Bush K. Characterization of β-lactamases. Classification of β-lactamases: groups 1, 2a, 2b, and 2b′. Classification of β-lactamases: groups 2c, 2d, 2e, 3, and 4. Antimocrob Agents Chemother 1989; 33:259–263264–270271–276
    [Google Scholar]
  18. King J. D., Farmer T., Reading C., Sutherland R. Sensitivity to carbenicillin and ticarcillin, and the beta-lactamases of Pseudomonas aeruginosa in the UK in 1978–1979. J Clin Pathol 1980; 33:297–301
    [Google Scholar]
  19. Chen H. Y., Bonfiglio G., Allen M. Multicentre survey of the comparative in-vitro activity of piperacillin/tazobactam against bacteria from hospitalized patients in the British Isles. J Antimicrob Chemother 1993; 32:247–266
    [Google Scholar]
  20. Thabaut A., Philippon A., Meyran M. β-Lactamases of Pseudomonas aeruginosa and susceptibility against β-lactam antibiotics. Chemioterapia 1985; 4:36–42
    [Google Scholar]
  21. Tirado M., Roy C., Segura C., Reig R., Hermida M., Foz A. Incidence of strains producing plasmid determined β-lactamases among carbenicillin resistant Pseudomonas aeruginosa. J Antimicrob Chemother 1986; 18:453–458
    [Google Scholar]
  22. Liu P. Y. F., Gur D., Hall L. M. C., Livermore D. M. Survey of the prevalence of β-lactamases amongst 1000 Gram-negative bacilli isolated consecutively at the Royal London Hospital. J Antimicrob Chemother 1992; 30:429–447
    [Google Scholar]
  23. Stobberingh E. E., Houben A. W., Van Boven C. P. A. Distribution and characterization of β-lactamase-producing strains isolated in the southern part of the Netherlands. In Periti P., Grassi G. G. (eds) Current chemotherapy and immunotherapy. Proceedings of the 12th International Congress of Chemotherapy Washington DC: American Society for Microbiology; 1982747–748
    [Google Scholar]
  24. Livermore D. M., Pitt T. L., Jones C. S., Crees-Morris J. A., Williams R. J. PSE-4 β-lactamase: a serotype-specific enzyme in Pseudomonas aeruginosa. J Med Microbiol 1985; 19:45–53
    [Google Scholar]
  25. Poole K., Krebes K., McNally C., Neshat S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacterial 1993; 175:7363–7372
    [Google Scholar]
  26. Zimmermann W. Penetration of β-lactam antibiotics into their target enzymes in Pseudomonas aeruginosa: comparison of a highly sensitive mutant with its parent strain. Antimicrob Agents Chemother 18:94–100
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-43-4-300
Loading
/content/journal/jmm/10.1099/00222615-43-4-300
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error